Latest Breaking News On - Donald bergstrom - Page 1 : vimarsana.com

Cellectis S A : Report of the board of directors to the Combined Shareholders Meeting - June 28, 2024

Cellectis S A : Report of the board of directors to the Combined Shareholders Meeting - June 28, 2024
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

North carolinaUnited statesFrance generalAxel sven malkomesDavid sourdiveRainer boehmMarc dunoyerPierre bastidDonalda bergstromDonald bergstromInstitut pasteurLaurent arthaudJean pierre garnierEnyo pharmaCroix jarryFusion pharmaceuticals

Cellectis S A : Report of the board of directors to the combined shareholders meeting - June 27, 2023

CELLECTIS A corporation with a share capital of 2,779,188.40 euros Headquarters: 8, rue de la Croix Jarry - 75013 Paris . | June 1, 2023

France generalUnited statesPierre bastidLaurent arthaudDonald bergstromAxel sven malkomesCroix jarryInstitut pasteurDavid sourdiveRainer boehmJean pierre garnierAnnick schwebigNextvivo incCarrier global corpHumanigen incTribogenics inc

Cellectis Provides Business Update and Reports Fourth Quarter and Full Year 2022 Financial Results

Cellectis Provides Business Update and Reports Fourth Quarter and Full Year 2022 Financial Results
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesFrance generalNorth carolinaAshleyr robinsonMonica guzmanMark frattiniAxel sven malkomesDonald bergstromArthur strilMarina konoplevaDonalda bergstromPascalyne wilsonPurpose acquisition companyNature communicationsHead of research

Cellectis Provides Business Update and Reports Financial Results for Second Quarter 2022

04.08.2022 - IND clearance received from FDA for UCART20x22 for the treatment of Non-Hodgkin LymphomaCellectis unveiled novel immune-evasive universal allogeneic CAR T-cell in Nature Communications; awarded oral presentation at ASGCT in MayMr. Axel-Sven .

New yorkUnited statesFrance generalNorth carolinaAshleyr robinsonAxel sven malkomesDonald bergstromArthur strilLes laboratoires servierDonalda bergstromMargaret gandolfoPascalyne wilsonHead of researchCalyxt incAllogene therapeutics incAmerican society of cell

Cellectis Announces the Appointment of Axel-Sven Malkomes &

NEW YORK, June 28, 2022 (GLOBE NEWSWIRE) Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company.

New yorkUnited statesFrance generalNorth carolinaUnited kingdomAshleyr robinsonMargaret gandolfoDonalda bergstromAxel sven malkomesArthur strilDonald bergstromPascalyne wilsonHead of researchCellectis the company euronext growthMerck kgaUniversity of washington